Kampala, Uganda (AP) — Alice Nekesa didn’t know she was infected with a malaria-causing parasite until it was too late. She was in her fourth month of pregnancy when she began bleeding last year. This was a miscarriage that was later caused by her untreated malaria.
A Ugandan farmer recently said she regretted the loss of what was her second child.
Variations of such cases have been commonly reported by Ugandan healthcare workers who witness deaths or enthusiastic babies within days of undiagnosed malaria. Death is part of the wider deaths linked to mosquito-borne disease. The most deadly in all of AfricaHowever, people who are easily treated in adults seeking timely medical care.
Until recently, a major gap in malaria treatment has been the way to care for newborns and infants infected with malaria, which were not strong enough to administer regular medications. That changed last month when Swiss health regulator approved it Medicine at Novartis, a pharmaceutical company based in Basel For babies weighing 2-5 kilograms (almost 4.5-11 pounds).
Swissmedic said the treatment, a sweet-tasting tablet that disperses in syrup when dropped in water, was approved in conjunction with the World Health Organization under a rapid approval process to allow developing countries to access much-needed treatments.
According to the WHO, 1.5 billion people in Africa accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023. Over three-quarters of these deaths were among the children.
Uganda, an East African country of 45 million, had 12.6 million malaria cases and nearly 16,000 deaths in 2023.
Nigeria, Congo and Uganda are the most burdened African countries in that order. malariaa parasitic disease that is transmitted to humans through the bites of infected mosquitoes that thrive and reproduce in stagnant water.
The drug, approved by Swiss authorities, is known in some countries as Coartem Baby and in others as Riamet Baby, but is a combination of two anti-malaria. This is a low-dose version of a tablet previously approved for other age groups, including older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose and toxicity.
Ugandan authorities working to update clinical guidelines for the treatment of malaria say the new drug will be rolled out as soon as possible. It is not available at public hospitals yet.
The development of Coartem Baby has given many hope, and local health workers and others say that medicines save the lives of many infants.
Ronald Serfusa, a top malaria employee in the Wakiso district, shares the border with Kampala’s Uganda capital and believes Coartem babies will be available “very quickly” and that priorities are sensitive to those stuck in the treatment.
He said some private pharmacies already have access to Coartem Baby “seasoned with orange or mango” to make it taste like an infant.
During the so-called malaria season, which coincides with the rainy season twice a year, a long line of sick patients grows outside government-run health centres across Uganda. Often, the baby is a woman tied to her back.
Health workers are currently trained to understand that “malaria can be linked to newborns,” even when other dangerous conditions such as sepsis exist, Self-Sha said.
“If they don’t expand their investigation to make malaria suspect, they won’t notice,” he said.
The Malaria Consortium, a global nonprofit based in London, explained in a statement that it has been approved by Coartem Baby as “a major leap to save the lives of young children in countries affected by malaria.”
In addition to Uganda, the drug will be deployed in Burkina Faso, Cote Daiboir, Kenya, Malawi, Mozambique, Nigeria and Tanzania, the group said.
Jane Nabakuza, pediatrician with Uganda’s Malaria Control Program, said the government hopes to make it free of charge to patients. The US has reduced its foreign aid program Early this year.
Malaria funding from external sources, including a global fund to combat AIDS, malaria and tuberculosis, remains available for programs such as indoor spraying to kill mosquitoes that spread the parasites that cause malaria.
Due to the lack of funds, “We’re focusing on people who are actually prone to malaria and malaria deaths, and these are children under the age of five,” she said.
___
The Associated Press receives financial support from the Gates Foundation for coverage of Africa’s global health and development. AP is solely responsible for all content. Find the AP standard A list of supporters and funded coverage areas to work with charities ap.org.
